Newsfeeds Archive - Page 394 of 461

1 minute read

Walmart To Let Go More Than 1,000 Employees At Atlanta Fulfillment Center

October 7, 7:38 AM

As per a Worker Adjustment and Retraining Notification, Walmart Inc (NYSE: WMT) looks to lay off 1,458 workers at the e-commerce fulfillment center in Fulton Parkway in Atlanta, Georgia.

WMT

1 minute read

Amid FDA Dispute, Juul Labs Cancels Overseas Expansion Plans, Refinances Some Debt

By Vandana Singh

October 7, 6:49 AM

Juul Labs Inc's CEO, K.C. Crosthwaite, said the company is taking all necessary steps to keep it afloat. Altria Group Inc (NYSE: MO) has a minority stake in the company.

1 minute read

Verve’s Stock Price Could Continue To Rise Through Clinical Progress – Despite Worries About “DeeperPocketed” Competition

By Vandana Singh

October 6, 3:49 PM

Credit Suisse has initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a $48 target price. Its lead assets…

MRK

1 minute read

Analyst Initiates Coverage On This Genetic Testing Stock With Ongoing Transformation

By Vandana Singh

October 6, 1:43 PM

Stephens initiated coverage on Myriad Genetics Inc (NASDAQ:MYGN) with an Equal-Weight rating and a price target of $22. The analyst writes that…

MYGN

1 minute read

Stephen Initiates This Spatial Biology Player Citing Strong Competitive Position

By Vandana Singh

October 6, 1:40 PM

Stephens started coverage on Akoya Biosciences Inc (NASDAQ:AKYA) with an Overweight rating and price target of $16. The analyst views Akoya…

AKYA

1 minute read

This Analyst Cuts Integer’s Price Target Citing Choppy Macro Environment

By Vandana Singh

October 6, 1:38 PM

Integer Holdings Corp (NYSE:ITGR) said Q3 sales were negatively impacted by approximately $15 million, primarily due to deteriorating delivery performance and…

ITGR

1 minute read

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction

By Vandana Singh

October 6, 12:46 PM

Cyclerion Therapeutics Inc (NASDAQ:CYCN) is reprioritizing development programs and focusing resources and capabilities on candidates for mitochondrial diseases. The company has…

CYCN

1 minute read

Surrozen Inks Strategic Partnership With Boehringer Ingelheim For Retinal Disease Candidate

By Vandana Singh

October 6, 12:33 PM

Surrozen Inc (NASDAQ:SRZN) entered into a collaboration and license agreement with Boehringer Ingelheim to research and develop SZN-413 for retinal diseases. SZN-413 is…

SRZN

1 minute read

Aldeyra’s ADX-2191 Aces Late-Stage Study In Rare Vision Disorder

By Vandana Singh

October 6, 12:23 PM

Aldeyra Therapeutics Inc (NASDAQ:ALDX) achieved the primary endpoint in Part 1 of the Phase 3 GUARD Trial of ADX-2191 (methotrexate injection,…

ALDX

1 minute read

CytoSorbents Secures US Govt Contract For Customized Filter Freeze-Dried Universal Plasma

By Vandana Singh

October 6, 11:12 AM

The U.S. Army Medical Research Acquisition Activity has awarded CytoSorbents Corp (NASDAQ:CTSO) a three-year Phase 3 contract valued at $4.3 million for…

CTSO